Channel Therapeutics Corporation (PTHS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Channel Therapeutics Corp...

    NYSE: PTHS · Real-Time Price · USD
    23.72
    0.00 (0.00%)
    At close: Aug 28, 2025, 9:42 AM

    Channel Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 n/a -0.92 -4.46 -11.43
    PEG Ratio
    		 n/a -0.00 -0.03 n/a
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 n/a -1.06 -2.96 n/a
    P/FCF Ratio
    		 n/a -6.94 -6.99 n/a
    P/OCF Ratio
    		 n/a -6.94 -6.99 n/a
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 -0.81 -0.2 -0.15 n/a
    Quick Ratio
    		 0.34 0.01 0.01 n/a
    Current Ratio
    		 0.34 0.01 0.01 n/a
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -9.63 -13.23 -16.51 -3.32K
    Return on Equity
    		 2.93 1.15 0.66 n/a
    Return on Assets
    		 -5.81 -76.57 -44.64 n/a
    Return on Invested Capital
    		 14.34 1.33 0.73 n/a
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist